Loading...
Wenzhou Kangning Hospital Co., Ltd.
2120.HK•HKSE
Healthcare
Medical - Care Facilities
HK$8.92
HK$-0.16(-1.76%)
Wenzhou Kangning Hospital Co., Ltd. (2120.HK) Financial Performance & Income Statement Overview
Review Wenzhou Kangning Hospital Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.63%
↑ 3.63%
Operating Income Growth
-25.72%
↓ 25.72%
Net Income Growth
-23.66%
↓ 23.66%
Operating Cash Flow Growth
-62.41%
↓ 62.41%
Operating Margin
4.56%
↑ 4.56%
Gross Margin
26.50%
↑ 26.50%
Net Profit Margin
3.97%
↑ 3.97%
ROE
5.22%
↑ 5.22%
ROIC
3.26%
↑ 3.26%
Wenzhou Kangning Hospital Co., Ltd. (2120.HK) Income Statement & Financial Overview
Review Wenzhou Kangning Hospital Co., Ltd.'s (2120.HK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $412.67M | $412.67M | $414.48M | $414.48M |
| Cost of Revenue | $303.76M | $303.76M | $304.18M | $304.18M |
| Gross Profit | $108.90M | $108.90M | $110.30M | $110.30M |
| Gross Profit Ratio | $0.26 | $0.26 | $0.27 | $0.27 |
| R&D Expenses | $9.47M | $9.47M | $8.79M | $8.79M |
| SG&A Expenses | $73.47M | $73.47M | $54.75M | $54.75M |
| Operating Expenses | $103.14M | $103.14M | $78.39M | $78.39M |
| Total Costs & Expenses | $406.90M | $406.90M | $382.57M | $382.57M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $41.36M | $41.36M | $19.51M | $19.51M |
| EBITDA | $68.12M | $68.12M | $65.92M | $65.92M |
| EBITDA Ratio | $0.17 | $0.17 | $0.16 | $0.16 |
| Operating Income | $5.76M | $5.76M | $31.91M | $31.91M |
| Operating Income Ratio | $0.01 | $0.01 | $0.08 | $0.08 |
| Other Income/Expenses (Net) | -$2.47M | -$2.47M | -$1.16M | -$1.16M |
| Income Before Tax | $3.29M | $3.29M | $30.76M | $30.76M |
| Income Before Tax Ratio | $0.008 | $0.008 | $0.07 | $0.07 |
| Income Tax Expense | $592816.00 | $592816.00 | $8.26M | $8.26M |
| Net Income | $7.44M | $7.44M | $25.36M | $25.36M |
| Net Income Ratio | $0.02 | $0.02 | $0.06 | $0.06 |
| EPS | $0.10 | $0.10 | $0.34 | $0.34 |
| Diluted EPS | $0.10 | $0.10 | $0.34 | $0.34 |
| Weighted Avg Shares Outstanding | $75.22M | $75.22M | $74.60M | $74.60M |
| Weighted Avg Shares Outstanding (Diluted) | $73.96M | $73.96M | $74.60M | $74.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan